Keudell Connect Biopharma Holdings LTD Transaction History
Keudell
- $341 Million
- Q2 2024
A detailed history of Keudell transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Keudell holds 32,200 shares of CNTB stock, worth $41,538. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,200
Previous 19,700
63.45%
Holding current value
$41,538
Previous $34,000
41.18%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
2.98MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.04MShares$2.64 Million2.22% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$658,8040.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny212KShares$273,8670.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$134,0190.0% of portfolio
-
Geode Capital Management, LLC Boston, MA28KShares$36,0690.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $71M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...